The ACCD
has Imatinib regularly scheduled quarterly meetings, as well as emergency meetings to address urgent or priority issues. The agenda of the quarterly meetings includes a discussion of issues remaining from the previous meeting, a situation update on immunization and priority communicable diseases in the country, and a review of the implementation and effectiveness of current prevention and control strategies, including recently enacted recommendations. The agenda also includes new issues related to communicable diseases and immunization. Time is allocated to discuss any other matter, as well as correspondence from outside agencies or individuals. The sessions may include technical presentations by relevant experts, event-based surveillance reports from various sources, research study findings, field supervision reports, AEFI investigations, or disease outbreak reports. In contrast, the agenda of emergency sessions is limited to a discussion of specific issues. The minutes of both types of sessions are circulated P450 inhibitor to all ACCD members at least two weeks before the next meeting. However, unlike in many industrialized countries, the meeting minutes are not accessible to the general public
in either print form or online, nor are they officially available to anyone other than ACCD members. The minutes are provided to observers for the sessions that they attend. Unlike advisory committees on immunization practice in many countries, the mandate of the ACCD goes beyond vaccines, to include providing guidance on all types of communicable diseases and interventions for their control (Fig. 1). In addition to
addressing vaccine-preventable diseases, the Committee deals with priority infectious diseases such as dengue, leptospirosis and malaria. For example, the ACCD approved the decision to integrate leprosy services provided by a centralized, vertical program into the general health services, once the prevalence of the disease 17-DMAG (Alvespimycin) HCl was reduced to elimination level. And during a leptospirosis outbreak in 2008, the ACCD approved chemoprophylaxis with doxycycline for selected high-risk groups. In addition, the Committee has approved new guidelines for treatment of malaria and is currently assessing the feasibility of using bio-larvicides to control dengue. In the rest of this paper, we focus on the areas that the ACCD addresses in regards to vaccines and immunization. Staff of the Epidemiology Unit of the MOH use Sri Lanka’s well-functioning passive disease surveillance system as well as special surveillance systems for specific diseases [9] to assess the situation regarding vaccine-preventable diseases and to recommend action. With the evolving communicable disease profile in the country, the need sometimes arises to add new diseases to the disease surveillance system to facilitate decision-making.